ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,663Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 973

$544K Total Retail Price of All Prescriptions

Rank: 113 out of 973

463 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 656 625 1 2
SIMVASTATIN 532 459 2 1
LISINOPRIL 459 405 3 3
FUROSEMIDE 424 411 4 6
METFORMIN HCL 372 335 5 8
WARFARIN SODIUM 355 332 6 10
POTASSIUM CHLORIDE 348 326 7 9
OMEPRAZOLE 337 288 8 5
HYDROCHLOROTHIAZIDE 246 226 9 11
NAMENDA 222 222 10 31
METOPROLOL TARTRATE 206 181 11 13
HYDROCODONE-ACETAMINOPHEN 200 145 S3 12 4
SERTRALINE HCL 195 183 13 21
AMLODIPINE BESYLATE 193 193 14 7
DONEPEZIL HCL 168 168 15 26
PANTOPRAZOLE SODIUM 159 146 16 37
LOVASTATIN 156 153 17 38
ATENOLOL 146 119 18 16
TRAMADOL HCL 142 123 19 18
LOSARTAN POTASSIUM 140 136 20 19
GABAPENTIN 137 126 21 12
METOPROLOL SUCCINATE 129 129 22 17
TAMSULOSIN HCL 121 121 23 28
PRAVASTATIN SODIUM 116 93 24 22
ALENDRONATE SODIUM 111 101 25 24
BUMETANIDE 110 99 26 103
FENOFIBRATE 103 78 27 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 82 28 25
CITALOPRAM HBR 96 73 29 14
DIGOXIN 94 94 30 32
ATORVASTATIN CALCIUM 91 84 31 15
CARVEDILOL 90 67 32 27
GLIPIZIDE ER 82 60 33 135
GLIMEPIRIDE 80 80 34 41
MELOXICAM 78 55 35 23
GLYBURIDE 68 68 R 36 59
BENAZEPRIL HCL 68 68 36 62
DIOVAN 68 65 36 63
CRESTOR 67 55 39 34
NEXIUM 61 36 40 30
OXYBUTYNIN CHLORIDE ER 60 60 41 125
ACTOS 60 41 41 119
LANTUS 58 56 43 39
GEMFIBROZIL 58 42 43 83
SPIRONOLACTONE 58 58 43 49
LEVOFLOXACIN 56 53 46 84
ENABLEX 55 55 47 174
ALLOPURINOL 54 46 48 29
MIRTAZAPINE 53 40 49 43
CLOPIDOGREL 52 36 50 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 45 51 76
TEKTURNA 50 50 52 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.